Livongo Health (NASDAQ:LVGO) Earns Outperform Rating from Analysts at Leerink Swann

Leerink Swann assumed coverage on shares of Livongo Health (NASDAQ:LVGO) in a research report sent to investors on Monday morning, The Fly reports. The brokerage issued an outperform rating and a $50.00 target price on the stock.

A number of other research firms have also recently commented on LVGO. Chardan Capital began coverage on Livongo Health in a research note on Friday, August 16th. They set a neutral rating and a $40.00 target price on the stock. Piper Jaffray Companies began coverage on Livongo Health in a research note on Monday. They set an overweight rating and a $40.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock has an average rating of Buy and a consensus price target of $44.20.

LVGO opened at $34.95 on Monday. Livongo Health has a one year low of $31.60 and a one year high of $45.68.

In other news, Director Hemant Taneja acquired 2,678,571 shares of the company’s stock in a transaction that occurred on Monday, July 29th. The shares were bought at an average price of $28.00 per share, with a total value of $74,999,988.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Ab (Publ) Kinnevik acquired 3,141,795 shares of the company’s stock in a transaction that occurred on Monday, July 29th. The stock was purchased at an average cost of $28.00 per share, for a total transaction of $87,970,260.00. The disclosure for this purchase can be found here.

About Livongo Health

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Read More: 52-Week High/Low Prices For Stock Selection

The Fly

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.